Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 325

1.

The role of 18F-FDG PET/CT for initial staging of nasal type natural killer/T-cell lymphoma: a comparison with conventional staging methods.

Moon SH, Cho SK, Kim WS, Kim SJ, Chan Ahn Y, Choe YS, Lee KH, Kim BT, Choi JY.

J Nucl Med. 2013 Jul;54(7):1039-44. doi: 10.2967/jnumed.112.113399. Epub 2013 May 8.

2.

Utility of 18F-FDG PET/CT for staging NK/T-cell lymphomas.

Wu HB, Wang QS, Wang MF, Li HS, Zhou WL, Ye XH, Wang QY.

Nucl Med Commun. 2010 Mar;31(3):195-200. doi: 10.1097/MNM.0b013e32833310fa.

PMID:
20009963
3.

Regional nodal staging with 18F-FDG PET-CT in non-small cell lung cancer: Additional diagnostic value of CT attenuation and dual-time-point imaging.

Li M, Wu N, Liu Y, Zheng R, Liang Y, Zhang W, Zhao P.

Eur J Radiol. 2012 Aug;81(8):1886-90. doi: 10.1016/j.ejrad.2011.03.074. Epub 2011 Apr 20.

PMID:
21511421
4.

The utility of positron emission tomography/computed tomography in the staging of extranodal natural killer/T-cell lymphoma.

Fujiwara H, Maeda Y, Nawa Y, Yamakura M, Ennishi D, Miyazaki Y, Shinagawa K, Hara M, Matsue K, Tanimoto M.

Eur J Haematol. 2011 Aug;87(2):123-9. doi: 10.1111/j.1600-0609.2011.01645.x.

PMID:
21557776
5.

Diagnostic value of 18F-FDG PET/CT for cutaneous extranodal natural killer/T-cell lymphoma, nasal type.

Liu C, Zhang Y, Zhang Y, Wang M, Liu R, Liu X, Hu S.

Nucl Med Commun. 2015 Dec 11. [Epub ahead of print]

PMID:
26657218
6.

Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose for initial staging of hodgkin lymphoma: a single center experience in Brazil.

Cerci JJ, Pracchia LF, Soares Junior J, Linardi Cda C, Meneghetti JC, Buccheri V.

Clinics (Sao Paulo). 2009;64(6):491-8.

7.

18F-fluorodeoxyglucose positron emission tomography in the staging and prognosis of T cell lymphoma.

Casulo C, Schöder H, Feeney J, Lim R, Maragulia J, Zelenetz AD, Horwitz S.

Leuk Lymphoma. 2013 Oct;54(10):2163-7. doi: 10.3109/10428194.2013.767901. Epub 2013 Mar 4.

8.

18F-FDG-PET in patients with malignant lymphoma having long-term follow-up: staging and restaging, and evaluation of treatment response and recurrence.

Isohashi K, Tatsumi M, Higuchi I, Inoue A, Nakajo K, Ishikawa J, Shimosegawa E, Kanakura Y, Nakamura H, Hatazawa J.

Ann Nucl Med. 2008 Nov;22(9):795-802. doi: 10.1007/s12149-008-0186-4. Epub 2008 Nov 28.

PMID:
19039558
9.

F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas.

Hernandez-Pampaloni M, Takalkar A, Yu JQ, Zhuang H, Alavi A.

Pediatr Radiol. 2006 Jun;36(6):524-31. Epub 2006 Apr 19.

PMID:
16622665
10.

Clinical impact of whole body FDG-PET on the staging and therapeutic decision making for malignant lymphoma.

Sasaki M, Kuwabara Y, Koga H, Nakagawa M, Chen T, Kaneko K, Hayashi K, Nakamura K, Masuda K.

Ann Nucl Med. 2002 Jul;16(5):337-45.

PMID:
12230093
11.

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.

Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa.

PMID:
19687736
12.

The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.

Schrepfer T, Haerle SK, Strobel K, Schaefer N, Hälg RA, Huber GF.

Laryngoscope. 2010 May;120(5):937-44. doi: 10.1002/lary.20843.

PMID:
20422687
13.

Disseminated extranodal NK/T-cell lymphoma, nasal type, with multiple subcutaneous nodules: utility of 18F-FDG PET in staging.

Berk V, Yildiz R, Akdemir UO, Akyurek N, Karabacak NI, Coskun U, Benekli M.

Clin Nucl Med. 2008 May;33(5):365-6. doi: 10.1097/RLU.0b013e31816a7a23.

PMID:
18431160
14.

The value of [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography in extranodal natural killer/T-cell lymphoma.

Karantanis D, Subramaniam RM, Peller PJ, Lowe VJ, Durski JM, Collins DA, Georgiou E, Ansell SM, Wiseman GA.

Clin Lymphoma Myeloma. 2008 Apr;8(2):94-9. doi: 10.3816/CLM.2008.n.010.

PMID:
18501102
15.

In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.

Berthet L, Cochet A, Kanoun S, Berriolo-Riedinger A, Humbert O, Toubeau M, Dygai-Cochet I, Legouge C, Casasnovas O, Brunotte F.

J Nucl Med. 2013 Aug;54(8):1244-50. doi: 10.2967/jnumed.112.114710. Epub 2013 May 14.

16.

Utility of (18)F-FDG PET-CT in staging and restaging of patients with malignant salivary gland tumours: a single-institutional experience.

Sharma P, Jain TK, Singh H, Suman SK, Faizi NA, Kumar R, Bal C, Malhotra A, Kumar R.

Nucl Med Commun. 2013 Mar;34(3):211-9. doi: 10.1097/MNM.0b013e32835bc4c4.

PMID:
23353886
17.

Staging in childhood lymphoma: differences between FDG-PET and CT.

Hermann S, Wormanns D, Pixberg M, Hunold A, Heindel W, Jürgens H, Schober O, Franzius C.

Nuklearmedizin. 2005 Feb;44(1):1-7.

PMID:
15711722
18.

18F-fluorodeoxyglucose-positron emission tomography in evaluation of primary cutaneous lymphoma.

Kumar R, Xiu Y, Zhuang HM, Alavi A.

Br J Dermatol. 2006 Aug;155(2):357-63.

PMID:
16882175
19.

[Comparison of 18F-FDG coincidence SPECT imaging and computed tomography in the initial staging and therapeutic evaluation of lymphomas].

Qiao WL, Zhao JH, Wang C, He ZY, Wang TS, Xing Y.

Zhonghua Zhong Liu Za Zhi. 2007 Jul;29(7):536-9. Chinese.

PMID:
18069637
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk